Literature DB >> 2542205

Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma.

H Tsuda1, S Hirohashi, Y Shimosato, Y Ino, T Yoshida, M Terada.   

Abstract

We examined the incidence of point mutation in codons 12, 13 and 61 of c-Ki-ras and N-ras genes in human hepatocellular carcinoma (HCC) using the polymerase chain reaction and oligonucleotide hybridization techniques. Among 34 tissues specimens surgically resected from 30 patients and 5 cell lines of human HCC, only two had ras point mutations; in one case, codon 12 of c-Ki-ras was altered from GGT, coding glycine, to GTT, coding valine; in the other case, codon 61 of N-ras was altered from CAA, coding glutamine, to AAA, coding lysine. Thus, point-mutational activation of ras oncogenes is an uncommon event in human HCC.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542205      PMCID: PMC5917712          DOI: 10.1111/j.1349-7006.1989.tb02290.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  16 in total

1.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

2.  Oncogenes in human primary hepatic cancer.

Authors:  J R Gu; L F Hu; Y C Cheng; D F Wan
Journal:  J Cell Physiol Suppl       Date:  1986

3.  Base composition-independent hybridization in tetramethylammonium chloride: a method for oligonucleotide screening of highly complex gene libraries.

Authors:  W I Wood; J Gitschier; L A Lasky; R M Lawn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

4.  Structure and activation of the human N-ras gene.

Authors:  E Taparowsky; K Shimizu; M Goldfarb; M Wigler
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

5.  Amino-acid substitution at codon 13 of the N-ras oncogene in rectal cancer in a Japanese patient.

Authors:  N Nitta; M Ochiai; M Nagao; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1987-01

6.  A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides.

Authors:  M Verlaan-de Vries; M E Bogaard; H van den Elst; J H van Boom; A J van der Eb; J L Bos
Journal:  Gene       Date:  1986       Impact factor: 3.688

7.  Three different mutations in codon 61 of the human N-ras gene detected by synthetic oligonucleotide hybridization.

Authors:  J L Bos; M Verlaan-de Vries; A M Jansen; G H Veeneman; J H van Boom; A J van der Eb
Journal:  Nucleic Acids Res       Date:  1984-12-11       Impact factor: 16.971

8.  Characterization of integrated hepatitis B viral DNA cloned from a human hepatoma and the hepatoma-derived cell line PLC/PRF/5.

Authors:  A Dejean; C Brechot; P Tiollais; S Wain-Hobson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

9.  Pathology of small hepatocellular carcinoma. A proposal for a new gross classification.

Authors:  T Kanai; S Hirohashi; M P Upton; M Noguchi; K Kishi; M Makuuchi; S Yamasaki; H Hasegawa; K Takayasu; N Moriyama
Journal:  Cancer       Date:  1987-08-15       Impact factor: 6.860

10.  A novel combination of K-ras and myc amplification accompanied by point mutational activation of K-ras in a human lung cancer.

Authors:  Y Taya; K Hosogai; S Hirohashi; Y Shimosato; R Tsuchiya; N Tsuchida; M Fushimi; T Sekiya; S Nishimura
Journal:  EMBO J       Date:  1984-12-01       Impact factor: 11.598

View more
  21 in total

1.  Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinoma.

Authors:  Bert H O'Neil; Laura W Goff; John Sae Wook Kauh; Jonathan R Strosberg; Tanios S Bekaii-Saab; Ruey-Min Lee; Aslamuzzaman Kazi; Dominic T Moore; Maria Learoyd; Richard M Lush; Said M Sebti; Daniel M Sullivan
Journal:  J Clin Oncol       Date:  2011-04-25       Impact factor: 44.544

2.  Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma.

Authors:  Yu-Jing Zhang
Journal:  World J Hepatol       Date:  2010-03-27

3.  Correlation between Bcl-2 expression and histopathology in diethylnitrosamine-induced mouse hepatocellular tumors.

Authors:  G H Lee
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 4.  Genetics of hepatocellular carcinoma.

Authors:  Andreas Teufel; Frank Staib; Stephan Kanzler; Arndt Weinmann; Henning Schulze-Bergkamen; Peter-R Galle
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

Review 5.  Personalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker Selection.

Authors:  Bingnan Zhang; Richard S Finn
Journal:  Liver Cancer       Date:  2016-05-10       Impact factor: 11.740

6.  Synergistic role of Sprouty2 inactivation and c-Met up-regulation in mouse and human hepatocarcinogenesis.

Authors:  Susie A Lee; Sara Ladu; Matthias Evert; Frank Dombrowski; Valentina De Murtas; Xin Chen; Diego F Calvisi
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

7.  Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways.

Authors:  Chunmei Wang; Salvatore Delogu; Coral Ho; Susie A Lee; Bing Gui; Lijie Jiang; Sara Ladu; Antonio Cigliano; Frank Dombrowski; Matthias Evert; Diego F Calvisi; Xin Chen
Journal:  J Hepatol       Date:  2012-05-19       Impact factor: 25.083

8.  Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis.

Authors:  Chuan-Rui Xu; Susie Lee; Coral Ho; Prashant Bommi; Shi-Ang Huang; Siu Tim Cheung; Goberdhan P Dimri; Xin Chen
Journal:  Mol Cancer Res       Date:  2009-11-24       Impact factor: 5.852

9.  A rare point mutation in the Ras oncogene in hepatocellular carcinoma.

Authors:  Akinobu Taketomi; Ken Shirabe; Jun Muto; Shohei Yoshiya; Takashi Motomura; Yohei Mano; Tohru Ikegami; Tomoharu Yoshizumi; Kenji Sugio; Yoshihiko Maehara
Journal:  Surg Today       Date:  2012-12-26       Impact factor: 2.549

Review 10.  The genetics of human cancer: implications for ecotoxicology.

Authors:  G McMahon
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.